Possible new treatment for spinal cord injuries identified in animal studies

An experimental drug has shown promise as a potential therapy for spinal cord injuries in animal studies. The compound, 4-aminopyridine-3-methanol, works in a similar way as a drug previously developed at Purdue, 4-aminopyridine (4-AP), which has been approved by the U.S. Food and Drug Administration to treat multiple sclerosis. Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, […]

Continue reading »

New light shed on mechanisms of paediatric epilepsy

Research by Cardiff University has uncovered the brain activity that underlies absence epilepsy, offering new hope for the development of innovative therapies for this disabling disease. Absence epilepsy—the most common form of epilepsy in children and teenagers—causes episodes of lack of awareness which are often mistaken for daydreaming. The brain activity that causes this form of epilepsy has remained poorly […]

Continue reading »

Science of racism examined in new set of research articles

White supremacist marches and xenophobic Twitter rants have brought overt racism to the center of public attention in recent months. Even still, subtle, structural, and systemic forms of racism continue to lurk in what is becoming an increasingly racially diverse United States. In a new collection of scholarly articles, psychological scientists describe research on the enduring and often hidden presence […]

Continue reading »

Insurance denials for new hepatitis C drugs remain high nationwide, study suggests

Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the U.S. in 2014. But both public and private insurers continue to deny coverage for these costly drugs at high rates nationwide, despite efforts to remove treatment restrictions, according to a new study published in Open Forum Infectious Diseases. The […]

Continue reading »

No new adverse events reported for DTaP vaccination

(HealthDay)—No new or unexpected safety issues have been identified in association with diphtheria-tetanus-acellular pertussis (DTaP) vaccines in the United States, according to a study published online June 4 in Pediatrics. Pedro L. Moro, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues searched the Vaccine Adverse Event Reporting System (VAERS) for U.S. reports of […]

Continue reading »

New study points to a potential ‘Achilles heel’ in brain cancer

Scientists at Virginia Commonwealth University believe they have uncovered an “Achilles heel” of glioblastoma multiforme (GBM), the most common and deadly form of brain cancer. Their study published this week in the Proceedings of the National Academy of Sciences details how a mechanism that protects glioma stem cells can potentially be exploited to develop new and more effective treatments for […]

Continue reading »

Scientists discover a new way to control blood pressure

New, improved ways to fight hypertension and low blood pressure may be in the offing, thanks to a discovery of how blood pressure is controlled. National University of Singapore researchers have found a new means of controlling blood pressure that involves the protein galectin-1, present in blood vessels and various other tissues. The researchers showed that galectin-1 reduces the activity […]

Continue reading »
1 15 16 17 18 19 23